Animalcare Group plc

Equities

ANCR

GB0032350695

Pharmaceuticals

Market Closed - London S.E. 11:35:29 2024-04-22 am EDT 5-day change 1st Jan Change
217 GBX 0.00% Intraday chart for Animalcare Group plc -1.36% +27.65%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Animalcare Group plc, 2023 Earnings Call, Apr 15, 2024
Animalcare to sell 33% stake in STEM Animal Health to Dechra AN
Dechra Pharmaceuticals Limited reached agreement in principle to acquire 33.34% stake in STEM Animal Health Inc. for $4.7 million. CI
FTSE 100 Closes Down 0.1% as ECB Rate-Cut Hopes Wane DJ
Animalcare ups dividend on 2023 results as chair announces retirement AN
Transcript : Animalcare Group plc, 2023 Earnings Call, Apr 09, 2024
Earnings Flash (ANCR.L) ANIMALCARE GROUP Reports FY23 Revenue GBP74.4M MT
Earnings Flash (ANCR.L) ANIMALCARE GROUP Posts FY23 EPS GBX2.00 MT
Animalcare Group plc Proposes Final Dividend for the Year Ended 31 December 2023, Payable on July 19, 2024 CI
Animalcare Group plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI
AB Dynamics trades in line; Verditek sells solar arm AN
Animalcare Group to Sells Identicare in GBP25 Million Deal MT
AIM WINNERS & LOSERS: Image Scan falls on slower start to 2024 AN
BG Bidco 21 Limited acquired unknown majority shares in Identicare Limited from Animalcare Group plc for £24.9 million. CI
Treatt revenue falls; Secure Trust profit picks up AN
EARNINGS: Andrews Sykes revenue up; Safestay optimistic AN
Transcript : Animalcare Group plc, H1 2023 Earnings Call, Sep 26, 2023
Earnings Flash (ANCR.L) ANIMALCARE GROUP Posts H1 Revenue GBP36.7M MT
Animalcare Group plc Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Animalcare Group plc Provides Revenue Guidance for the Full Year 2023 CI
Animalcare Group plc Declares an Interim Dividend, Payable on November 17, 2023 CI
Kane Biotech Engages Research Capital to Conduct Strategic Review of STEM Animal Health MT
Volex, Eleco, Fintel trading in line with forecast AN
Animalcare Group plc Provides Earnings Guidance for the Six Months Ended 30 June 2023 CI
Kane Biotech Says Skout's Honor Pet Supply Signed coactiv+ Animal Health Licensing Pact; Up Nearly 9% MT
Chart Animalcare Group plc
More charts
Animalcare Group plc is a United Kingdom-based international veterinary sales and marketing company. The Company is focused on bringing products to market through its own development pipeline, partnerships and through acquisitions. The Company develops and commercializes prescription and over-the-counter pharmaceutical products that improve animal health and wellbeing. These are developed in-house, acquired from other companies or in-licensed from its partners. The Company manages an international supply chain, including specialist veterinary wholesalers and distributors. It partners with companies to commercialize products across Europe. The Company operates in three categories within the veterinary market: companion animals, equine and other, and production animals. Its product pipeline is Daxocox, which is a differentiated COX-2 inhibitor for the treatment of chronic pain in dogs. The Company operates in seven countries and exports to about 40 countries in Europe and worldwide.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.17 GBP
Average target price
2.935 GBP
Spread / Average Target
+35.25%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ANCR Stock
  4. News Animalcare Group plc
  5. Animalcare Group to Sells Identicare in GBP25 Million Deal